ARLnow.com

Ask Eli: The next chapter in residential design

This regularly scheduled sponsored column is written by Eli Tucker, Arlington-based Realtor and Arlington resident. If you would like to work with Eli and his team in Northern Virginia and the greater ...
24/7 Wall St

Eli Lilly Just Opened the Door to Even Greater GLP-1 Growth

Eli Lilly is building an insurmountable lead in GLP-1 drugs through superior clinical efficacy of tirzepatide, direct-to-employer distribution that bypasses pharmacy benefit managers, and a ...
Yahoo

Head-to-head trial shows Eli Lilly’s oral GLP-1 orforglipron outperforms oral semaglutide

Add Yahoo as a preferred source to see more of our stories on Google. A clinical trial for diabetes that pit orforglipron, a diabetes and weight-loss pill developed by Eli Lilly, against oral ...
Chicago Tribune

Eli Harper will do anything for No. 1 Kouts. Playing with these teammates ‘means a lot to me.’

Kouts senior center Eli Harper cuts an imposing figure. Make no mistake, the 6-foot-3, 250-pound Harper has an edge to him too. “He’s kind of our enforcer,” Kouts coach Kevin Duzan said. “If things ...
Reuters

Eli Lilly builds $1.5 billion stockpile of weight-loss pill ahead of FDA decision

Feb 12 (Reuters) - Eli Lilly (LLY.N), opens new tab had $1.5 billion worth of pre-launch inventory of its experimental oral weight-loss drug, a filing showed on Thursday, ahead of an expected decision ...
The Motley Fool

Eli Lilly Is Partnering with Gene-Editing Start-up Seamless Therapeutics. Here's What Investors Need to Know.

Eli Lilly's GLP-1 drugs have seen strong demand, which has investors excited about the future. The company knows that its GLP-1 success won't last forever and is exploring additional paths. Eli Lilly ...
The Motley Fool

Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.

Eli Lilly's stock price rose sharply as demand for its GLP-1 drugs increased. Novo Nordisk is the second fiddle in GLP-1 drugs, but its GLP-1 pill is seeing strong demand. Medical device maker ...
NBC Sports

Eli Tomac crashes in Turn 1 of the Glendale SuperMotocross race, loses red plate

Eli Tomac was involved in a first-turn crash in Round 5 of the SuperMotocross World Championship at State Farm Stadium in Glendale, Arizona, and was slow to rise. After remounting his KTM in 22nd, he ...
CNBC

We're raising our price target on Eli Lilly as the GLP-1 leader delivers a huge beat

Eli Lilly 's fourth-quarter results blew past Wall Street estimates on Wednesday, as key GLP-1 drugs, Mounjaro for diabetes and Zepbound to treat obesity, grew triple-digits — and there's still plenty ...
Morning Call PA

Eli Lilly to build $3.5 billion Lehigh Valley complex, company’s first Pa. plant

Global pharmaceutical firm Eli Lilly and Co. will invest $3.5 billion to build a manufacturing plant in Upper Macungie Township that is expected to create 850 jobs. “This is the largest single project ...
AOL

Missed Out on Eli Lilly? This GLP-1 Stock Could Be a Bargain Buy.

Eli Lilly (NYSE: LLY) is the most valuable healthcare company in the world, with a market cap of around $950 billion. In the past five years, the stock price has soared an incredible 400%, thanks in ...
Bloomberg L.P.

Lilly Signs Seamless Gene-Editing Deal for Over $1.1 Billion

Eli Lilly & Co. struck a deal worth more than $1.1 billion with German biotech Seamless Therapeutics GmbH to develop gene therapies for hearing loss. Closely-held Seamless will design a type of enzyme ...